MultiversX vs Enzyme — how do they compare? MultiversX trades at Rp55,896 (market cap Rp1,69T, Rp150,83M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: MultiversX is far larger — about 12599.7× Enzyme's market cap, and MultiversX's circulating supply is 30,3M EGLD versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold MultiversX for 82 Days and Enzyme for 28 Days on average.
| EGLD | MLN | |
|---|---|---|
Market Cap | Rp1,69T | Rp134,13M |
Volume (24h) | Rp150,83M | Rp104,56M |
Circulating Supply | 30,3M EGLD | 3,3M MLN |
Typical Hold Time | 82 Days | 28 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
MultiversX (EGLD) is a blockchain protocol that seeks to offer extremely fast transaction speeds by using sharding. The project is known as a technology ecosystem for the new internet, which includes fintech, decentralized finance and the Internet of Things. The native token, EGLD, is used for paying network fees, staking and rewarding validators
Read more on EGLD →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →